Adagio Medical Holdings/$ADGM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Adagio Medical Holdings
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
- Ticker
- $ADGM
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 41
- Headquarters
- Laguna Hills, United States
- Website
- adagiomedical.com
ADGM Metrics
BasicAdvanced
$1.4M
-
-$40.72
0.07
-
Price and volume
Market cap
$1.4M
Beta
0.07
52-week high
$2.32
52-week low
$1.50
Financial strength
Current ratio
1.414
Quick ratio
1.024
Long term debt to equity
-62.101
Total debt to equity
-62.653
Interest coverage (TTM)
-6.38%
Profitability
EBITDA (TTM)
-18.984
Management effectiveness
Return on assets (TTM)
-35.52%
Return on equity (TTM)
-657.76%
Valuation
Price to book
-3.34
Price to tangible book (TTM)
-0.06
Price to free cash flow (TTM)
-0.075
Free cash flow yield (TTM)
-1,329.61%
Free cash flow per share (TTM)
-24.864
Growth
Earnings per share change (TTM)
-74.78%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.